2020/2021 Deadlines and Key Dates
- Deadline for new applications for an SRF research grant is January 10, 2021.
- Review of applications are conducted through May, 2021.
- Funding awarded by June 30, 2021.
Required Submission Materials
- Completed, signed application
- Letter from sponsoring principal investigator
- Relevant supplemental material appended to application
- Research proposal
- Three (3) letters of recommendation
Goals of the RFA
The goal of this Request For Applications is to foster the development of research that will advance our understanding of the pathogenesis of scleroderma and to promote the design, development, and pilot testing of hypothesis-driven, innovative therapeutic approaches.
The SRF seeks to advance research by promoting collaboration and cross-institutional cooperation among scientists in a variety of disciplines, attracting promising new scientists to scleroderma research, maintaining Scleroderma Centers of Excellence, and bringing new technology and thinking to the field of scleroderma research.
- US citizen or permanent resident
- Completion of PhD or MD prior to appointment
Before submitting a fellowship application, the applicant must identify a sponsoring institution and an individual who will serve as a sponsor and will supervise his/her training and research experience. The sponsoring institution may be private or public non-profit.
The applicant’s sponsor should be an active investigator in the area of the proposed research who will directly supervise the candidate’s research. The sponsor must document the availability of staff, research support, and facilities for high-quality research training.
Applicants who accept an award from the scleroderma research foundation will be asked to account for how they have spent their grants. Grant recipients will be required to attend the annual SRF Scientific Workshop to present their research.
Scientific Conduct and IRB Approval
The Scleroderma Research Foundation does not assume responsibility for the conduct of the investigation or the acts of the investigator, because the investigator’s conduct and actions are under the direction and control of the grantee institution and subject to the institution’s medical and scientific policies. Grantee institutions must safeguard the rights and welfare of individuals who participate as subjects in research activities by reviewing proposed activities through an Institutional Review Board (IRB) as specified by the National Institutes of Health (NIH) Office for Human Research Protections, DHHS (OHRP). Furthermore, grantee institutions must adhere to current US Department of Health and Human Services guidelines regarding financial conflict of interest, recombinant DNA, research misconduct, and vertebrate animals. The Awardee’s institution must ensure appropriate governance of animal studies as well as human studies.
Application Submission Procedures
- Download the SRF Postdoctoral Fellowship Grant Application.
- When you are ready to submit, contact firstname.lastname@example.org to request a Dropbox link where you will need to upload your signed application form, required research proposal, relevant appendix material, and three letters of recommendation.
- Please allow up to 24 hours to receive the Dropbox link.
- All submission materials must be received no later than January 10, 2021.
For questions: email email@example.com (please reference grant support)
Note: applicants from institutions that have a General Clinical Research Center (GCRC) funded by the NIH Center for Research Resources may wish to identify the GCRC as a resource for conducting the proposed research. If so, a letter of agreement from either the GCRC Program Director or Principal Investigator should be included with the application.
Fellows will be selected on the basis of previous achievements, the commitment of the applicant, sponsor and sponsoring institution to scleroderma research, the scientific and technical merit of the research proposal, and the relevance of the proposal to the SRF’s ongoing research program.
Criteria that will be used to make funding decisions include:
- Merit of the application
- Availability of funds
- Programmatic priorities